-
1 Comment
From a valuation standpoint, the stock is 90.2% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 11.0.
Based on the above factors, JD Health International Inc gets an overall score of 1/5.
| Exchange | HK |
|---|---|
| CurrencyCode | HKD |
| ISIN | KYG5074A1004 |
| Sector | Healthcare |
| Industry | Pharmaceutical Retailers |
| PE Ratio | 26.3 |
|---|---|
| Market Cap | 117B |
| Target Price | 41.0639 |
| Beta | 1.05 |
| Dividend Yield | None |
JD Health International Inc., an investment holding company, engages in the operation of an online healthcare platform in the People's Republic of China and internationally. It offers pharmaceutical and healthcare products through direct selling and an online retail pharmacy network. The company also provides online medical consultation, consumer healthcare, and health management services; hospital or doctor referral, health check-ups, genetic testing, and beauty care services; and intelligent healthcare solutions, as well as technical and advertising services. The company was incorporated in 2018 and is headquartered in Beijing, the People's Republic of China. JD Health International Inc. is a subsidiary of JD Jiankang Limited.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for 6618.HK using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
